New Market Study Published: Ukraine Pharmaceuticals & Healthcare Report Q3 2013
While we retain a bullish view on the long-term growth prospects of the Ukrainian pharmaceutical market, there remain many aspects of regulation and market access that must be resolved in order for the Ukrainian market to realise its full potential. Ukraine's membership of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) marks it out from Turkey and Russia, the two biggest markets outside of the European Union (EU) in the Central and Eastern Europe (CEE) region, and, therefore, we believe drugmakers will...
View full press release